{"grounding": "Rod and cone photoreceptors degenerate in retinitis pigmentosa and age-related macular degeneration, robbing the visual system of light-triggered signals necessary for sight. However, changes in the retina do not stop with the photoreceptors. A stereotypical set of morphological and physiological changes, known as remodeling, occur in downstream retinal neurons. Some aspects of remodeling are homeostatic, with structural or functional changes compensating for partial loss of visual inputs. However, other aspects are nonhomeostatic, corrupting retinal information processing to obscure vision mediated naturally by surviving photoreceptors or artificially by vision-restoration technologies. In this review, I consider the mechanism of remodeling and its consequences for residual and restored visual function; discuss the role of retinoic acid, a critical molecular trigger of detrimental remodeling; and discuss strategies for suppressing retinoic acid biosynthesis or signaling as therapeutic possibilities for mitigating vision loss.", "generated_text": "Photoreceptor degenerative disorders, such as retinitis pigmentosa and age-related macular degeneration, are leading causes of blindness worldwide, characterized by the progressive loss of photoreceptors and subsequent retinal remodeling. This remodeling includes synaptic plasticity changes that further impair vision by disrupting the neural circuitry essential for visual signal processing. This study explores therapeutic strategies aimed at suppressing retinal remodeling to mitigate vision loss. By targeting the underlying mechanisms of synaptic plasticity and neuronal reorganization, we aim to preserve retinal function and delay the progression of vision impairment. Our findings suggest that interventions focusing on the stabilization of synaptic connections and inhibition of maladaptive plasticity could offer a promising avenue for the treatment of photoreceptor degenerative disorders. This research underscores the importance of addressing retinal remodeling as a critical component in the development of effective therapies for preserving vision in affected individuals.", "label": 1}